Geographical Group Reporting Submission

Following the launch of the new cochrane.org website, we are working on restructuring the Community site.
Until this work is finished, some content you find here may still be relevant but some may be outdated.
To find still published content on this site, use the Search box above.

Group Cochrane Madrid (IRYCIS/Universidad Francisco de Vitoria)

Name Jesús Lopez-Alcalde

Activity name / title Published Cochrane intervention review: Interleukin-receptor antagonist and tumour necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases

Which function does this relate to?

Tier one N/A

Tier two N/A

Tier three N/A

Tier four N/A

Evidence production Cochrane review and evidence production

Date

Start date 21-08-2024

Proposed end date 21-08-2024

on-going No

Was this activity in collaboration with other organization(s) or partner(s)? If so which? No

Person to contact if any queries about this activity Jesus Lopez-Alcalde
cochrane.madrid@ufv.es

Type of activity Evidence production

Please give additional activity details (i.e., reach, impact, duration, return on investment) Publication of a Cochrane review that is expected to have a significant impact on decision-making processes

Link and documents

Link Cochrane review

By checking this box, my center consents to the use of these photos for Cochrane internal and external purposes, such as websites, reports, social media, etc. No